U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756138) titled 'Filsuvez in Moderate-to-Severe Epidermolysis Bullosa Simplex' on July 24. Brief Summary: T... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitaxe... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07753928) titled 'PENTAGON: MS-Related Disability Worsening and Thalamic Volume Loss' on Aug. 03. Brief Summ... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Ad... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755540) titled 'Group Music Therapy for Chronic Pain Management in Active Duty Service Members: A Randomize... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755189) titled 'Night Driving After Trifocal Versus Monofocal IOL Implantation' on Aug. 05. Brief Summary:... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More
U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755826) titled 'Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive T... Read More
Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More